Low-grade Glioma Clinical Trials

67 clinical trials for Low-grade Glioma across international registries, including 23 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• A Study to Learn About the Study Medicine Called PF-07799544 as Monotherapy or in Combination in People With Advanced Solid Tumors — RECRUITING · PHASE1
• A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma — RECRUITING · PHASE3
• Dabrafenib and Trametinib for BRAF V600 Mutant Low-Grade Gliomas — RECRUITING · PHASE2
• A Study to Assess a Medicine Called Tovorafenib in Japanese Children and Young Adults With Brain Tumours — RECRUITING · PHASE1
• Rehabilitation and Longitudinal Follow-up of Cognition in Adult Lower Grade Gliomas — RECRUITING · NA
• MAPK Inhibition Combined With Anti-PD1 Therapy for BRAF-altered Pediatric Gliomas — RECRUITING · PHASE1
• Trametinib and Everolimus for Treatment of Pediatric and Young Adult Patients With Recurrent Gliomas (PNOC021) — RECRUITING · PHASE1
• Low-grade Gliomas in Argentina: Incidence, Survival, and Therapeutic Strategies — RECRUITING
• Evaluation of 18F-Fluciclovine Positron Emission Tomography - Magnetic Resonance Imaging (PET-MRI) in LGG — RECRUITING · PHASE1
• Efficacy of Laser Interstitial Thermal Therapy in Young Persons With Low-grade Glioma — RECRUITING · NA
• Post-Operative Dosing of Dexamethasone in Patients With Brain Tumors After a Craniotomy, PODS Trial — RECRUITING · PHASE2
• SJ901: Evaluation of Mirdametinib in Children, Adolescents, and Young Adults With Low-Grade Glioma — RECRUITING · PHASE1
• A Living Tissue Bank of Patient-Derived Organoids From Glioma Tumors — RECRUITING
• A Vaccine Trial for Low Grade Gliomas — RECRUITING · PHASE2
• HOBSCOTCH-CA (HOme-Based Self-management and COgnitive Training CHanges Lives in Brain CAncer) — RECRUITING · NA
• Pilot Study of Vinblastine and Tovorafenib in Pediatric Patients With Recurrent/Progressive RAF Altered Low Grade Gliomas — RECRUITING · PHASE1
• A Study to Evaluate Tovorafenib in Pediatric and Young Adult Participants With Relapsed or Progressive Low-Grade Glioma and Advance Solid Tumors — RECRUITING · PHASE2
• Monitoring of Patients With Low-grade Gliomas Using Circulating miRNA — RECRUITING
• Feasibility of Individualized, Model-guided Optimization of Proton Beam Treatment Planning in Patients With Low Grade Glioma — RECRUITING · PHASE2
• Binimetinib in Patients With BRAF Fusion-positive Low-grade Glioma or Pancreatic Cancer (Perfume) — RECRUITING · PHASE2
• CEST in Low-grade Glioma Study — RECRUITING · NA
• LOGGIC Core BioClinical Data Bank — RECRUITING
• Radiotherapy Versus Radiotherapy Combined With Temozolomide in High-risk Low-grade Gliomas After Surgery — RECRUITING · PHASE2
• A Study of the Drugs Selumetinib Versus Carboplatin/Vincristine in Patients With Neurofibromatosis and Low-Grade Glioma — ACTIVE_NOT_RECRUITING · PHASE3
• Studying the Biology of IDH-mutant Gliomas Via Longitudinal Observation of 2-hydroxyglutarate (2-HG) Using MR Spectroscopy — SUSPENDED · PHASE2
• Mind-Body Intervention in Glioma Couples — ACTIVE_NOT_RECRUITING · NA
• A Phase I Study of Mebendazole for the Treatment of Pediatric Gliomas — ACTIVE_NOT_RECRUITING · PHASE1
• Positron Emission Tomography/Computed Tomography (PET/CT) Imaging in Patients Diagnosed With a Glioma — NOT_YET_RECRUITING · PHASE2
• Niraparib In Recurrent IDH 1/2 Gliomas — ACTIVE_NOT_RECRUITING · PHASE1
• Neurocognitive Assessment CNSL and LGG — NOT_YET_RECRUITING · NA
• A Study of Avutometinib for People With Solid Tumor Cancers — ACTIVE_NOT_RECRUITING · PHASE1
• DAY101 vs. Standard of Care Chemotherapy in Pediatric Participants With Low-Grade Glioma Requiring First-Line Systemic Therapy (LOGGIC/FIREFLY-2) — ACTIVE_NOT_RECRUITING · PHASE3
• Selumetinib in Treating Young Patients With Recurrent or Refractory Low Grade Glioma — ACTIVE_NOT_RECRUITING · PHASE1
• Trametinib for Pediatric Neuro-oncology Patients With Refractory Tumor and Activation of the MAPK/ERK Pathway. — ACTIVE_NOT_RECRUITING · PHASE2
• Seizure Control as a New Metric in Assessing Efficacy of Tumor Treatment in Patients With Low Grade Glioma — ACTIVE_NOT_RECRUITING
• Tazemetostat in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With EZH2, SMARCB1, or SMARCA4 Gene Mutations (A Pediatric MATCH Treatment Trial) — COMPLETED · PHASE2
• BGB-290 and Temozolomide in Treating Isocitrate Dehydrogenase (IDH)1/2-Mutant Grade I-IV Gliomas — ACTIVE_NOT_RECRUITING · PHASE1
• Fluoroethyltyrosine for Evaluation of Intracranial Neoplasms — COMPLETED · PHASE2
• DAY101 In Gliomas and Other Tumors — COMPLETED · PHASE1
• Fluorescence Spectroscopy Guided Surgery — COMPLETED · PHASE1
• Proton Radiation Therapy for Gliomas — ACTIVE_NOT_RECRUITING · NA
• Nivolumab in Patients With IDH-Mutant Gliomas With and Without Hypermutator Phenotype — ACTIVE_NOT_RECRUITING · PHASE2
• SonoClear Acoustic Coupling Fluid (ACF) Mimicking Brain Tissue — COMPLETED · NA
• FCN-159 Monotherapy Versus Chemotherapy by Investigator's Choice in Pediatric Low-grade Glioma Patients With BRAF Alteration — NOT_YET_RECRUITING · PHASE3
• Proton Radiotherapy for Pediatric Brain Tumors Requiring Partial Brain Irradiation — COMPLETED · PHASE2
• A Phase II Trial of Poly-ICLC for Low-Grade Gliomas — TERMINATED · PHASE2
• Olaparib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Defects in DNA Damage Repair Genes (A Pediatric MATCH Treatment Trial) — COMPLETED · PHASE2
• A Study Comparing Two Carboplatin Containing Regimens for Children and Young Adults With Previously Untreated Low Grade Glioma — ACTIVE_NOT_RECRUITING · PHASE3
• FG001 in Subjects with Meningiomas or Presumed Low-Grade Gliomas Scheduled for Neurosurgery — OTHER · PHASE2
• Expanded Access Program (EAP) for Tovorafenib (DAY101) in RAF-Altered, Relapsed or Refractory Low-Grade Glioma — OTHER

Refine this search